Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Comparing Contemporary Antidotes: Is New Better Than Old?
Track:
Sessions
Program Code: 209-L01
Date: Monday, December 4, 2006
Time: 2:00 PM to 5:00 PM
MODERATOR:
Daniel J. Cobaugh, Pharm.D., FAACT, Director of Research, ASHP Research and Education Foundation, Bethesda, MD
SPEAKER(S):
Daniel J. Cobaugh, Pharm.D., FAACT, Director of Research, ASHP Research and Education Foundation, Bethesda, MD
Methanol and Ethylene Glycol Poisoning: Ethanol vs. Fomepizole
Rebeca C. Gracia, Pharm.D., DABAT, Director, North Texas Poison Center, Parkland Health and Hospital System, Dallas
Hydroxycobalamin or the Cyanide Antidote Kit: Which Is It?
Edward P. Krenzelok, Pharm.D., DABAT, Director, Pittsburgh Poison Center at Children’s Hospital of Pittsburgh, PA
Acetaminophen Toxicity: Oral vs. IV Acetylcysteine
Jude T. McNally, R.Ph., DABAT, Managing Director, Arizona Poison and Drug Information Center, University of Arizona College of Pharmacy, Tucson
Snakebite: Which Antivenom Should I Use?
Description
Learning Objectives: Identify the antidotes most commonly used in clinical toxicology practice. Describe common clinical issues associated with the use of antidotes in hospitalized patients. Describe pharmacoeconomic issues associated with the use of antidotes in clinical toxicology practice.